US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 5, 2022 (4 years ago)

Ipamorelin Acetate/Sermorelin Acetate

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

What was recalled

Ipamorelin Acetate/Sermorelin Acetate (1 mg/1 mg)/mL (10 mL) Injection, 10 mL vials, Rx Only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081

Recalling firm
North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0777-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sermorelin recalls

See all
Class II · Moderate risk Terminated

Sermorelin Acetate 1 mg/mL

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0781-2022
Class II · Moderate risk Terminated

Sermorelin Acetate

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0060-00 D-0797-2022